GBA1 and Parkinson disease: The role of undegraded substrates like β-glucosylceramide (GlcCer) and β-glucosylsphingosine (GlcSph), and the subsequent alterations in the immune and inflammatory responses, appear to be the most relevant hypotheses regarding the molecular pathway linking PD patients carrying GBA mutations to MM.